MedPath

Structural and functional imaging of the frontoparietal cerebral cortex in the detection of mild cognitive impairment

Completed
Conditions
Milde cognitieve stoornissen (geheugenpoli)
Mild cognitive impairment
preclinical dementia
Registration Number
NL-OMON32688
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Patients should have a least an impairment in the memory domain, with a CDR score 0.5, whereas participants in the control group should be cognitive healthy as determined by neuropsychological assessments. For both groups, the age range is between 58-68 years old. Only male patients will be included, who are right-handed or ambidexter and who have an average level of education. Participants have to fill in an informend consent and a screening questionnaire that contains questions about home adress, age, handedness, sensory functioning, profession, educational level, lifestyle, health and MRI-exclusion criteria

Exclusion Criteria

Participants who do not fulfill the MRI-safety criteria are not allowed in the study Furthermore, people with reduced vision, psychoactive medication use, substance abuse, past or present psychiatric or neurological disorders and structural abnormalities in the brain are not included in the study. Control participants with neuropsychological test results below average (based on normative data) will be excluded.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main outcome measures are performance (mean reaction time and accuracy) and<br /><br>the Blood Oxygen Level Dependent (BOLD) response during the functional tasks.<br /><br>Firstly, the differences in BOLD response between groups will be calculated.<br /><br>Secondly, the functional network underlying this performance will be analyzed<br /><br>by using fractional anisotropy measures and granger causality mapping.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>White matter lesions will be taken in consideration and resting state<br /><br>connectivity will be analyzed</p><br>
© Copyright 2025. All Rights Reserved by MedPath